Revenue Breakdown
Composition ()
No data
Revenue Streams
Neogen Corp (NEOG) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Culture Media & Other, accounting for 37.8% of total sales, equivalent to $79.08M. Other significant revenue streams include Bacterial & General Sanitation and Rodenticides, Insecticides & Disinfectants. Understanding this composition is critical for investors evaluating how NEOG navigates market cycles within the Medical Equipment, Supplies & Distribution industry.
Profitability & Margins
Evaluating the bottom line, Neogen Corp maintains a gross margin of 37.29%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -2.39%, while the net margin is -7.09%. These profitability ratios, combined with a Return on Equity (ROE) of -25.25%, provide a clear picture of how effectively NEOG converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, NEOG competes directly with industry leaders such as LMAT and ESTA. With a market capitalization of $2.43B, it holds a significant position in the sector. When comparing efficiency, NEOG's gross margin of 37.29% stands against LMAT's 71.66% and ESTA's 70.46%. Such benchmarking helps identify whether Neogen Corp is trading at a premium or discount relative to its financial performance.
